Most recently, it's been identified that conolidine and the above mentioned derivatives act around the atypical chemokine receptor three (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds into a wide array of endogenous opioids. As opposed to most opioid receptors, this receptor acts to be a scavenger and doesn't activa… Read More